InvestorsHub Logo
Followers 74
Posts 9169
Boards Moderated 0
Alias Born 04/25/2002

Re: None

Friday, 12/24/2021 10:22:27 AM

Friday, December 24, 2021 10:22:27 AM

Post# of 44690
Clinical Trials... What's Next !!!........

Inhaled Zyesami - 144 participants
Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 (AVICOVID-2)

Estimated Primary Completion: Dec 15, 2021
Estimated Study Completion: Dec 31, 2021
https://clinicaltrials.gov/ct2/show/NCT04360096

Inhaled Aviptadil - 82 participants
Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS

Estimated Primary Completion: Dec 2021
Estimated Study Completion: Apr 2022
https://clinicaltrials.gov/ct2/show/NCT04536350